Project Grant R01HL179616
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of Minnesota a Project Grant of $543,957 under the Cardiovascular Diseases Research program (CFDA 93.837) for research addressing the maturation of human pluripotent stem cell-derived cardiomyocytes (HPSC-CMs). The grant, awarded July 6, 2026, with completion targeted for May 31, 2030, will support the development and validation of computational and experimental...
- Federal Grant Award Summary The University of Minnesota received a $657,595 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 22, 2026, with completion targeted for February 28, 2030. The grant funds the development of novel statistical methods and computational tools for high-dimensional mediation analysis to elucidate molecular mechanisms underlying cardiovascular disease (CVD). The research...
- Federal Grant Award Summary The Regents of the University of Minnesota received a $174,528 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025 through August 31, 2030. This award supports reverse translational research to identify novel treatment targets for atrial myopathy, a condition involving structural, mechanical, or electrophysiological changes in the atria that may...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a $429,000 Project Grant to the Regents of the University of Michigan on August 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop a rapid, non-contrast, low-field magnetic resonance imaging (MRI) pipeline for detecting pulmonary embolism (PE). The project, which extends through July 31, 2027, focuses on creating an efficient 3D, contrast-free MRI protocol utilizing...
- Federal Project Grant Award Summary The University of Minnesota received a $1.57 million Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 1, 2026, with completion by February 29, 2028. The award funds mechanistic research into chronic graft-versus-host disease (CGVHD) pathobiology and the development of novel anti-fibrotic therapies. Using state-of-the-art murine models and advanced molecular...
- Summary of Federal Project Grant Award The National Heart, Lung, and Blood Institute (NHLBI) awarded the Regents of the University of Minnesota a Project Grant totaling $389,748 under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with completion targeted for July 31, 2027. This award funds a proof-of-concept research initiative to evaluate carotid pulse arrival time (CPAT) as a potential non-invasive biomarker for monitoring ascending thoracic aortic...
- Federal Grant Award Summary Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received a $1,537,726 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 3, 2025, with completion targeted for May 31, 2029. The award funds demonstration of feasibility for AutoCMR (autonomous cardiac magnetic resonance imaging), a push-button, time-resolved 3D cardiac MRI protocol...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Endeavor Health Clinical Operations (doing business as Evanston Hospital) a $1.55 million Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) for the period July 15, 2026 through March 31, 2028. The funded research project, "Improved Cardiovascular MRI Using Equilibrium Phase BT1RESS MR Angiography," develops and validates an advanced magnetic resonance imaging technique...
- Federal Project Grant Award Summary Mayo Clinic received a $745,851 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through August 31, 2030. The award supports a five-year research initiative examining the integration of inspiratory muscle training (IMT) into cardiac rehabilitation (CR) protocols for patients with heart failure with reduced ejection fraction (HFrEF). The...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Mayo Clinic a $756,906 project grant (CFDA 93.837 – Cardiovascular Diseases Research) commencing September 1, 2025, and concluding June 30, 2029, to conduct a population-based study of deep learning measures of breast arterial calcification (BAC) for improving women's cardiovascular health using repurposed mammogram images. The research leverages automated artificial intelligence algorithms to...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $763,046 Project Grant to the Regents of the University of Minnesota on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate a rapid cardiac magnetic resonance imaging (CMR) protocol for heart failure diagnosis. The primary deliverable is a clinically optimized CMR examination protocol that reduces scan time from 45-60 minutes to approximately 10 minutes while eliminating the need for breath-holding. The project integrates deep learning-based computational imaging strategies to enable high-resolution real-time CMR sequences acquired during free breathing, including cine imaging, late gadolinium enhancement, and quantitative CMR acquisitions. This advancement addresses critical barriers to CMR adoption in clinical practice by reducing patient discomfort, examination duration, and associated costs while maintaining diagnostic capability to identify the presence, severity, and underlying cause of heart failure. The grant period extends through March 31, 2030, and will be executed at the University of Minnesota's Minneapolis facility. As a major research institution with established federal contracting experience and specialized medical imaging capabilities, the University of Minnesota will translate these computational imaging techniques into clinical practice, facilitating broader utilization of CMR in heart failure diagnostics across the healthcare system. The resulting rapid, patient-friendly CMR protocol is expected to improve diagnostic accuracy and clinical outcomes while reducing the economic burden of heart failure care on the Medicare system.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $763.0k | 7/10/26 |